SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-004097
Filing Date
2023-02-23
Accepted
2023-02-23 16:07:39
Documents
92
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ntla-20221231.htm   iXBRL 10-K 4376012
2 EX-10.30 ntla-ex10_30.htm EX-10 36316
3 EX-21.1 ntla-ex21_1.htm EX-21 6436
4 EX-23.1 ntla-ex23_1.htm EX-23 7054
5 EX-31.1 ntla-ex31_1.htm EX-31 15061
6 EX-31.2 ntla-ex31_2.htm EX-31 14733
7 EX-32.1 ntla-ex32_1.htm EX-32 13100
8 GRAPHIC img108155407_0.jpg GRAPHIC 871765
9 GRAPHIC img108155407_1.jpg GRAPHIC 266750
  Complete submission text file 0000950170-23-004097.txt   17298594

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ntla-20221231_pre.xml EX-101.PRE 518787
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ntla-20221231_def.xml EX-101.DEF 321617
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ntla-20221231_cal.xml EX-101.CAL 66379
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ntla-20221231_lab.xml EX-101.LAB 698452
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ntla-20221231.xsd EX-101.SCH 89034
86 EXTRACTED XBRL INSTANCE DOCUMENT ntla-20221231_htm.xml XML 2908435
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37766 | Film No.: 23659664
SIC: 2835 In Vitro & In Vivo Diagnostic Substances